Article info
PDFBrief communication
Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance
- Correspondence to Dr Jonathan Edward Millar, Critical Care Research Group, University of Queensland, The Prince Charles hospital, Brisbane QLD 4032, Australia ; j.millar{at}doctors.org.uk
Citation
Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance
Publication history
- Received December 18, 2017
- Revised March 15, 2018
- Accepted March 19, 2018
- First published April 5, 2018.
Online issue publication
January 15, 2019
Article Versions
- Previous version (5 April 2018).
- Previous version (22 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.